,20,21 Vamorolone, developed for clinical use through preclinical trials in mdx mice, provides a drug that could safely treat chronic inflammatory signaling, muscle pathology, weakness, cardiomyopathy, and low dystrophin levels in BMD. The gene discussed is DMD; the disease is cardiomyopathy.